YAHOO NEWS - PURA Announces $100k December Sale
Post# of 431
Posted On: 12/19/2016 9:13:23 AM
YAHOO NEWS - PURA Announces $100k December Sale
Puration Announces $100,000 December Sale Putting First Revenue On Books In 2016
DALLAS, TX / ACCESSWIRE / December 19, 2016 / Puration, Inc. (OTC PINK: PURA) today announced a $100,000 one-time sale to be realized entirely in the current month of December.
Puration entered the cannabis extraction business last year in 2015 acquiring a proprietary cannabis extraction technology. The Company has recently signed two collaboration agreements to infuse its cannabis extract into beverages generating revenue from the new cannabis extraction business starting in 2017. The first beverage expected to hit shelves early next year is the EVERx CBD Infused Bottled Water in production now as a part of a collaboration agreement with Alkame Water (ALKM). Puration anticipates generating $1 million in EVERx CBD Infused Bottled Water sales next year.
The sale announced today results from the Puration's previous water filter business. The Company has made a $100,000 one-time sale of water bottles produced and inventoried prior to its entry into the cannabis extraction business.
To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
Puration Announces $100,000 December Sale Putting First Revenue On Books In 2016
DALLAS, TX / ACCESSWIRE / December 19, 2016 / Puration, Inc. (OTC PINK: PURA) today announced a $100,000 one-time sale to be realized entirely in the current month of December.
Puration entered the cannabis extraction business last year in 2015 acquiring a proprietary cannabis extraction technology. The Company has recently signed two collaboration agreements to infuse its cannabis extract into beverages generating revenue from the new cannabis extraction business starting in 2017. The first beverage expected to hit shelves early next year is the EVERx CBD Infused Bottled Water in production now as a part of a collaboration agreement with Alkame Water (ALKM). Puration anticipates generating $1 million in EVERx CBD Infused Bottled Water sales next year.
The sale announced today results from the Puration's previous water filter business. The Company has made a $100,000 one-time sale of water bottles produced and inventoried prior to its entry into the cannabis extraction business.
To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
(1)
(0)Puration Inc (PURA) Stock Research Links
Scroll down for more posts ▼